An Assay for Immunogenic Detection of Anti‐PEG Antibody
- 22 July 2024
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 25 (16) , e202400316
Abstract
With the increasing use of polyethylene glycol (PEG) based proteins and drug delivery systems, anti‐PEG antibodies have commonly been detected among the population, causing the accelerated blood clearance and hypersensitivity reactions, poses potential risks to the clinical efficacy and safety of PEGylated drugs. Therefore, vigilant monitoring of anti‐PEG antibodies is crucial for both research and clinical guidance regarding PEGylated drugs. The enzyme‐linked immunosorbent assay (ELISA) is a common method for detecting anti‐PEG antibodies. However, diverse coating methods, blocking solutions and washing solutions have been employed across different studies, and unsuitable use of Tween 20 as the surfactant even caused biased results. In this study, we established the optimal substrate coating conditions, and investigated the influence of various surfactants and blocking solutions on the detection accuracy. The findings revealed that incorporating 1 % bovine serum albumin into the serum dilution in the absence of surfactants will result the credible outcomes of anti‐PEG antibody detection.Keywords
Funding Information
- National Natural Science Foundation of China (T2325010, 22205063)
This publication has 33 references indexed in Scilit:
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternativesAdvanced Drug Delivery Reviews, 2021
- Liposomal Irinotecan: A Review in Metastatic Pancreatic AdenocarcinomaDrugs, 2020
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticalsAdvanced Drug Delivery Reviews, 2020
- A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Polypeptides with High Zwitterion Density for Safe and Effective TherapeuticsAngewandte Chemie International Edition, 2018
- Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2017
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manageJournal of Controlled Release, 2013
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogsInternational Journal of Pharmaceutics, 2012
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent mannerJournal of Controlled Release, 2007